Dr.Jesus Soberino (Clinical oncologist)– Best Costs, Reviews – Book Your Consultation

Professional Experience

• Medical Oncologist and Head of Breast Cancer & Melanoma Unit, IOB – Hospital Quirón Barcelona (since 2016)
• Oncologist at Vall d’Hebron University Hospital and VHIO (2015–2016)
• Participated in clinical trials for CDK4/6 inhibitors and immune checkpoint therapies

Academic Contributions

• Regular lecturer at national and international oncology conferences
• Mentors junior oncologists and oncology researchers
• Research focus: overcoming hormone-therapy resistance and developing melanoma immunotherapies

Areas of Expertise

• Hormone-dependent breast cancer—optimizing endocrine treatments
• Management of hormone resistance in metastatic breast cancer
• Melanoma immunotherapy, including new checkpoint inhibitor combinations
• Holistic patient care—monitoring treatment response and side effects

Publications and Research

Dr. Soberino has participated in numerous clinical trials and contributed to scientific literature on breast cancer genomics and immunotherapy. His work includes:

• Research on the approval of palbociclib and ribociclib for metastatic breast cancer
• Studies leading to the approval of pembrolizumab and nivolumab/ipilimumab for metastatic melanoma
• Genomic studies in HER2-positive breast cancer published in EBioMedicine

Profiles available on PubMed and ResearchGate.

Patient Care Philosophy

• Emphasizes clear communication and shared decision-making
• Focuses on comprehensive care—medical needs and quality of life
• Available for online consultations for international patients
• Adopts a holistic approach, attentive to all aspects of patient wellbeing

Professional Affiliations

• Member of Breast Cancer Unit and Melanoma Unit at VHIO and Vall d’Hebron University Hospital
• Accredited by Vall d’Hebron Institute of Oncology

FAQs

Is Dr. Jesús Soberino board-certified?

Yes, he is certified in Medical Oncology in Spain and formally accredited through VHIO.

What types of treatments does he perform?

He treats breast cancer using hormone therapy and newer immunotherapy regimens for melanoma.

Does he treat international patients?

Yes, he offers online consultations and manages care for international patients at Hospital Quirón Barcelona.

How long is the typical hospital stay?

Duration varies—many treatments are outpatient; complex cases may require inpatient care with individualized planning.

What languages does he speak?

He speaks Spanish and English; hospital support is available in Catalan and other languages.

Can he help with resistant hormone-positive breast cancer?

Yes, he specializes in overcoming endocrine therapy resistance and leading related clinical trials.

Does he provide second opinions?

Yes, he offers remote second opinions and follow-up consultations internationally.